Magnesium Sulphate and Lidocaine in Hemodynamic Changes and Cortisol Levels

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

February 1, 2024

Study Completion Date

March 1, 2024

Conditions

Intubation Complication

Interventions

DRUG

Magnesium Sulfate 20 MG/ML

Administered intravenously with a dose of 30 mg/kg

DRUG

Lidocaine IV

Administered intravenously with a dose of 1.5mg/Kg

DRUG

saline solution

Administered intravenously with 20 ml

Trial Locations (1)

Adam Malik General Hospital, Medan

All Listed Sponsors

collaborator

Universitas Sumatera Utara

OTHER

lead

Arsil Radiansyah

OTHER

NCT06516861 - Magnesium Sulphate and Lidocaine in Hemodynamic Changes and Cortisol Levels | Biotech Hunter | Biotech Hunter